USEUCOM Clarifies Medical Entry Requirements for Contractors and Subcontractors

United States European Command (USEUCOM) medical-entry guidance applies to contractors and subcontractors traveling to support USEUCOM missions, regardless of how long they will be deployed. The duration-neutral scope is an important planning consideration for firms supporting short-term visits as well as extended deployments: personnel should not be assumed exempt from medical-readiness requirements simply because an assignment is brief. Companies should review the command’s theater medical clearance information and determine which requirements apply to their personnel and mission.

The guidance places responsibility on companies to evaluate whether employees are fit for deployment and to plan for access to necessary medical care and medication through host-nation medical facilities. That makes medical readiness part of operational planning, not solely an individual employee’s concern. Contractors may need to account for continuity of care, access to prescriptions, and the availability of appropriate host-nation services when preparing personnel to travel. Companies should build these considerations into deployment timelines and internal readiness processes.

Contractors should identify the supported Service component and coordinate medical-readiness and waiver procedures with that component before deployment. The listed waiver contacts cover Army, Air Force, Navy, Marine Corps, and special operations personnel. A specific timing requirement applies to Navy waiver submissions: they are due 30 days before deployment. This lead time makes early coordination particularly important for Navy-supported work and may affect mobilization schedules if a medical waiver is needed. Firms should confirm the relevant component’s process rather than assume a single command-wide waiver route.

The annual influenza vaccine is voluntary for covered personnel under this guidance and is no longer a mandatory theater-entry requirement. Companies should therefore avoid treating influenza vaccination as a required condition of entry based on this guidance. This clarification does not remove the broader obligation to assess fitness, arrange access to care and medication, or complete applicable readiness and waiver coordination. For capture, program, and deployment teams, the practical takeaway is to distinguish the voluntary influenza vaccine from other medical-entry requirements and to verify current procedures with the supported Service component.

• Scope: USEUCOM medical-entry guidance applies to contractors and subcontractors supporting USEUCOM missions, regardless of deployment duration.
• Employer responsibility: Companies must assess personnel fitness for deployment and plan for access to necessary care and medication through host-nation medical facilities.
• Pre-deployment action: Identify the supported Service component and coordinate its medical-readiness procedures before personnel travel.
• Waiver planning: Medical waiver contacts are listed for Army, Air Force, Navy, Marine Corps, and special operations personnel; confirm the applicable route for each deployment.
• Navy deadline: Navy waiver submissions are due 30 days before deployment, creating a specific planning milestone for Navy-supported work.
• Influenza vaccine: The annual influenza vaccine is voluntary under the guidance and is no longer a mandatory theater-entry condition.
• Compliance practice: Do not conflate the voluntary influenza vaccine with other medical-readiness obligations; confirm requirements and waiver processes with the supported component.
• Source: USEUCOM’s Theater Medical Clearance Information page provides the referenced guidance and waiver contacts.